Showing results (131-140 of 197) with videos related to
Sort By:
Pageof 20
European Journal of Cancer (Oxford, England : 1990)|August 2, 2011
A double-blind, randomised, placebo-controlled phase III intergroup study of gefitinib in patients with advanced NSCLC, non-progressing after first line platinum-based chemotherapy (EORTC 08021/ILCP 01/03)Rabab M Gaafar, Veerle F Surmont, Giorgio V Scagliotti, et al.Lung Cancer (Amsterdam, Netherlands)|January 9, 2026
Multi-omic screening for pleural mesothelioma in Asbestos-Exposed Populations: A literature review and RecommendationsKathleen Zwijsen, Ellen Heirwegh, Eline Schillebeeckx, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of CanadaJan P van Meerbeeck, Rabab Gaafar, Christian Manegold, et al.Oncoimmunology|February 16, 2017
Prognostic and predictive aspects of the tumor immune microenvironment and immune checkpoints in malignant pleural mesotheliomaElly Marcq, Vasiliki Siozopoulou, Jorrit De Waele, et al.Critical Reviews in Oncology/Hematology|April 30, 2015
What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysisGiuseppe Bronte, Christian Rolfo, Francesco Passiglia, et al.European Journal of Cancer (Oxford, England : 1990)|August 27, 2014
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: an individual patient pooled analysis of 10 European Organisation for Research and Treatment of Cancer Lung Cancer Group studies and an independent study validationBaktiar Hasan, Laurent Greillier, Athanasios Pallis, et al.Acta Chirurgica Belgica|April 13, 2017
Malignant pleural mesothelioma: single-institution experience of 101 patients over a 15-year periodAndreas Domen, Christophe De Laet, Wies Vanderbruggen, et al.Journal of Biomedical Optics|December 1, 2004
Raman microspectroscopic mapping studies of human bronchial tissueSenada Koljenović, Tom C Bakker Schut, Jan P van Meerbeeck, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 2, 2011
Serial measurements of mesothelioma serum biomarkers in asbestos-exposed individuals: a prospective longitudinal cohort studyKevin Hollevoet, Joris Van Cleemput, Joël Thimpont, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2008
EBUS-TBNA for the clarification of PET positive intra-thoracic lymph nodes-an international multi-centre experienceRobert C Rintoul, Kurt G Tournoy, Hesham El Daly, et al.Pageof 20